Clinical Trials Insight: 700028550
Phase of Trial: Phase II/III
Latest Information Update: 15 Jul 2008
At a glance
- Drugs Adipiplon; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Neurogen Corporation
- 15 Jul 2008 Status changed to suspended due to a higher than expected rate of adverse events, as reported by Neurogen.
- 09 Feb 2008 This trial has been modified from a phase III, parallel design to a phase II/III, crossover design.
- 16 Nov 2007 Status change